Search

3 result(s) for 'author#"Yi-Heng Lin"' within BMC

1. Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications

   Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy because of their high immunomodulation ability, tropism towards inflamed and injured tissues, and their easy access and iso...

   Authors: Wei-Zhan Zhuang, Yi-Heng Lin, Long-Jyun Su, Meng-Shiue Wu, Han-Yin Jeng, Huan-Cheng Chang, Yen-Hua Huang and Thai-Yen Ling

   Citation: Journal of Biomedical Science 2021 28:28

   Content type: Review

   Published on: 14 April 2021

   • View Full Text
   • View PDF

2. Prediction of B-cell epitopes using evolutionary information and propensity scales

   Development of computational tools that can accurately predict presence and location of B-cell epitopes on pathogenic proteins has a valuable application to the field of vaccinology. Because of the highly vari...

   Authors: Scott Yi-Heng Lin, Cheng-Wei Cheng and Emily Chia-Yu Su

   Citation: BMC Bioinformatics 2013 14(Suppl 2):S10

   Content type: Proceedings

   Published on: 21 January 2013

   This article is part of a Supplement: Volume 14 Supplement 2

   • View Full Text
   • View PDF

3. Calreticulin promotes EMT in pancreatic cancer via mediating Ca²⁺ dependent acute and chronic endoplasmic reticulum stress

   Our previous study showed that calreticulin (CRT) promoted EGF-induced epithelial-mesenchymal transition (EMT) in pancreatic cancer (PC) via Integrin/EGFR-ERK/MAPK signaling. We next investigated the novel sig...

   Authors: Weiwei Sheng, Guosen Wang, Jingtong Tang, Xiaoyang Shi, Rongxian Cao, Jian Sun, Yi Heng Lin, Chao Jia, Chuanping Chen, Jianping Zhou and Ming Dong

   Citation: Journal of Experimental & Clinical Cancer Research 2020 39:209

   Content type: Research

   Published on: 7 October 2020

   • View Full Text
   • View PDF